Figure 1.
Prostate cancer disease detection and prevalence of pelvic confined disease by 18F-DCFPyL PSMA targeted imaging in patients with biochemically recurrent prostate cancer. Percentage of 18F-DCFPyL PSMA targeted PET scans that detected prostate cancer stratified by absolute PSA (A) and PSADT (B). Prevalence of pelvic confined disease decreased with higher PSA (C) and shorter PSADTs (D).